Financial results - INOVA PHARMA S.R.L.

Financial Summary - Inova Pharma S.r.l.
Unique identification code: 43520953
Registration number: J23/43/2021
Nace: 4646
Sales - Ron
319.708
Net Profit - Ron
45.140
Employees
1
Open Account
Company Inova Pharma S.r.l. with Fiscal Code 43520953 recorded a turnover of 2024 of 319.708, with a net profit of 45.140 and having an average number of employees of 1. The company operates in the field of Comerţ cu ridicata al produselor farmaceutice și medicale having the NACE code 4646.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Inova Pharma S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - - - - - - 21.858 226.013 319.708
Total Income - EUR - - - - - - - 21.859 226.598 320.741
Total Expenses - EUR - - - - - - - 33.875 165.349 268.767
Gross Profit/Loss - EUR - - - - - - - -12.016 61.248 51.974
Net Profit/Loss - EUR - - - - - - - -12.235 51.644 45.140
Employees - - - - - - - 1 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 42.3%, from 226.013 euro in the year 2023, to 319.708 euro in 2024. The Net Profit decreased by -6.216 euro, from 51.644 euro in 2023, to 45.140 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Inova Pharma S.r.l.

Rating financiar

Financial Rating -
INOVA PHARMA S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Inova Pharma S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Inova Pharma S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Inova Pharma S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Inova Pharma S.r.l. - CUI 43520953

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - - - - - - 86 30.011 28.186
Current Assets - - - - - - - 18.186 145.385 213.147
Inventories - - - - - - - 13.513 10.809 45.283
Receivables - - - - - - - 2.771 111.498 113.680
Cash - - - - - - - 1.902 23.077 54.184
Shareholders Funds - - - - - - - -18.383 33.317 78.271
Social Capital - - - - - - - 41 40 40
Debts - - - - - - - 36.655 142.079 163.062
Income in Advance - - - - - - - 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4646 - 4646"
CAEN Financial Year 4646
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 213.147 euro in 2024 which includes Inventories of 45.283 euro, Receivables of 113.680 euro and cash availability of 54.184 euro.
The company's Equity was valued at 78.271 euro, while total Liabilities amounted to 163.062 euro. Equity increased by 45.140 euro, from 33.317 euro in 2023, to 78.271 in 2024.

Risk Reports Prices

Reviews - Inova Pharma S.r.l.

Comments - Inova Pharma S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.